ilmofosine has been researched along with sri 62-834 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croft, SL; Snowdon, D; Yardley, V | 1 |
| Arthur, G; Bittman, R | 1 |
| Civoli, F; Daniel, LW | 1 |
1 review(s) available for ilmofosine and sri 62-834
| Article | Year |
|---|---|
The inhibition of cell signaling pathways by antitumor ether lipids.
Topics: Animals; Antineoplastic Agents; Calcium; Furans; Humans; Phospholipid Ethers; Phosphorylcholine; Protein Kinases; Receptors, Cell Surface; Signal Transduction | 1998 |
2 other study(ies) available for ilmofosine and sri 62-834
| Article | Year |
|---|---|
The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Topics: Animals; Antineoplastic Agents; Chagas Disease; Cricetinae; Female; Furans; Leishmania donovani; Leishmaniasis, Visceral; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Phospholipid Ethers; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis, African | 1996 |
Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Survival; Culture Media, Serum-Free; Drug Resistance; Enzyme Activation; Furans; HL-60 Cells; Humans; Phospholipid Ethers; Phosphorylcholine; Protein Kinase C; Quaternary Ammonium Compounds; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1998 |